69.78
price down icon0.11%   -0.08
after-market After Hours: 69.78
loading
Edwards Lifesciences Corp stock is traded at $69.78, with a volume of 4.93M. It is down -0.11% in the last 24 hours and down -5.86% over the past month. Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.
See More
Previous Close:
$69.86
Open:
$69.96
24h Volume:
4.93M
Relative Volume:
1.06
Market Cap:
$41.16B
Revenue:
$6.60B
Net Income/Loss:
$4.16B
P/E Ratio:
10.07
EPS:
6.93
Net Cash Flow:
$490.10M
1W Performance:
-4.96%
1M Performance:
-5.86%
6M Performance:
-20.08%
1Y Performance:
-5.47%
1-Day Range:
Value
$69.10
$70.28
1-Week Range:
Value
$68.23
$72.34
52-Week Range:
Value
$58.93
$96.12

Edwards Lifesciences Corp Stock (EW) Company Profile

Name
Name
Edwards Lifesciences Corp
Name
Phone
(949) 250-2500
Name
Address
ONE EDWARDS WAY, IRVINE, CA
Name
Employee
19,800
Name
Twitter
@edwardslifesci
Name
Next Earnings Date
2024-10-24
Name
Latest SEC Filings
Name
EW's Discussions on Twitter

Compare EW with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
EW
Edwards Lifesciences Corp
69.78 41.16B 6.60B 4.16B 490.10M 6.93
Medical Devices icon
ABT
Abbott Laboratories
113.48 196.83B 41.22B 5.77B 6.49B 3.29
Medical Devices icon
SYK
Stryker Corp
383.42 146.17B 21.97B 3.59B 3.21B 9.33
Medical Devices icon
BSX
Boston Scientific Corp
98.66 145.41B 15.91B 1.79B 1.89B 1.21
Medical Devices icon
MDT
Medtronic Plc
88.08 112.94B 33.00B 4.29B 5.50B 3.27

Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-16-25 Downgrade Wolfe Research Peer Perform → Underperform
Dec-16-24 Upgrade BofA Securities Neutral → Buy
Oct-11-24 Resumed Morgan Stanley Equal-Weight
Sep-18-24 Downgrade Jefferies Buy → Hold
Jul-31-24 Upgrade Daiwa Securities Neutral → Outperform
Jul-29-24 Upgrade Wolfe Research Underperform → Peer Perform
Jul-25-24 Downgrade BofA Securities Buy → Neutral
Jul-25-24 Downgrade JP Morgan Overweight → Neutral
Jul-25-24 Downgrade Robert W. Baird Outperform → Neutral
Jul-25-24 Downgrade TD Cowen Buy → Hold
Jul-25-24 Downgrade Truist Buy → Hold
May-30-24 Initiated Goldman Buy
May-22-24 Upgrade Citigroup Neutral → Buy
May-14-24 Upgrade Deutsche Bank Hold → Buy
Mar-07-24 Upgrade BofA Securities Neutral → Buy
Feb-02-24 Upgrade Wells Fargo Equal Weight → Overweight
Jan-04-24 Downgrade Evercore ISI Outperform → In-line
Dec-11-23 Downgrade Citigroup Buy → Neutral
Nov-28-23 Downgrade Wolfe Research Peer Perform → Underperform
Sep-26-23 Upgrade Oppenheimer Perform → Outperform
Jul-19-23 Initiated Robert W. Baird Outperform
May-30-23 Resumed Morgan Stanley Overweight
Mar-29-23 Initiated UBS Neutral
Mar-08-23 Downgrade Wells Fargo Overweight → Equal Weight
Feb-06-23 Downgrade Raymond James Outperform → Mkt Perform
Jan-31-23 Downgrade Bernstein Outperform → Underperform
Jan-30-23 Downgrade Piper Sandler Overweight → Neutral
Dec-06-22 Downgrade Stifel Buy → Hold
Oct-28-22 Downgrade Oppenheimer Outperform → Perform
Oct-26-22 Initiated Mizuho Buy
Oct-18-22 Initiated Barclays Overweight
Oct-12-22 Initiated Jefferies Buy
Jul-29-22 Downgrade Canaccord Genuity Buy → Hold
Apr-13-22 Initiated Truist Buy
Apr-06-22 Initiated Wolfe Research Outperform
Mar-16-22 Upgrade Bernstein Mkt Perform → Outperform
Mar-02-22 Resumed BofA Securities Neutral
Feb-02-22 Upgrade UBS Neutral → Buy
Jan-27-22 Reiterated Citigroup Buy
Jan-27-22 Reiterated Evercore ISI Outperform
Jan-27-22 Reiterated Raymond James Outperform
Jan-27-22 Reiterated Stifel Buy
Jan-27-22 Reiterated UBS Neutral
Dec-17-21 Upgrade JP Morgan Neutral → Overweight
Dec-15-21 Upgrade Citigroup Neutral → Buy
Dec-10-21 Initiated RBC Capital Mkts Outperform
Dec-06-21 Upgrade Wells Fargo Equal Weight → Overweight
Jul-30-21 Reiterated Canaccord Genuity Buy
Jul-30-21 Reiterated Deutsche Bank Hold
Jul-30-21 Reiterated Jefferies Buy
Jul-30-21 Reiterated Morgan Stanley Overweight
Jul-30-21 Reiterated Oppenheimer Outperform
Jul-30-21 Reiterated Stifel Buy
Jul-30-21 Reiterated UBS Neutral
Jul-30-21 Reiterated Wells Fargo Equal Weight
May-25-21 Initiated Barclays Overweight
Apr-15-21 Initiated Atlantic Equities Neutral
Apr-05-21 Upgrade Evercore ISI In-line → Outperform
Dec-16-20 Downgrade Citigroup Buy → Neutral
Dec-11-20 Reiterated Canaccord Genuity Buy
Sep-11-20 Initiated Wolfe Research Underperform
Apr-28-20 Downgrade Wells Fargo Overweight → Equal Weight
Apr-17-20 Upgrade SVB Leerink Mkt Perform → Outperform
Mar-05-20 Initiated Citigroup Buy
Feb-13-20 Initiated Goldman Neutral
Feb-06-20 Resumed BTIG Research Neutral
Jan-10-20 Initiated Oppenheimer Outperform
Jan-02-20 Downgrade Evercore ISI Outperform → In-line
Oct-24-19 Reiterated Canaccord Genuity Buy
Sep-23-19 Initiated Piper Jaffray Overweight
Jul-24-19 Reiterated BofA/Merrill Buy
Mar-18-19 Reiterated Canaccord Genuity Buy
Jan-18-19 Upgrade BofA/Merrill Neutral → Buy
Jan-03-19 Initiated Deutsche Bank Hold
Nov-28-18 Initiated UBS Neutral
Oct-16-18 Initiated Barclays Underweight
Oct-02-18 Downgrade BofA/Merrill Buy → Neutral
Oct-02-18 Downgrade Guggenheim Buy → Neutral
View All

Edwards Lifesciences Corp Stock (EW) Latest News

pulisher
11:43 AM

Edwards Lifesciences CVP Daniel Lippis sells $34,382 in stock - MSN

11:43 AM
pulisher
07:58 AM

Seilern Investment Management Ltd Invests $109.49 Million in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

07:58 AM
pulisher
Jan 19, 2025

Gateway Investment Advisers LLC Acquires 5,726 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Jan 19, 2025
pulisher
Jan 18, 2025

Edwards Lifesciences Co. (NYSE:EW) Sees Significant Growth in Short Interest - MarketBeat

Jan 18, 2025
pulisher
Jan 18, 2025

Boston Common Asset Management LLC Lowers Stock Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Jan 18, 2025
pulisher
Jan 18, 2025

65,442 Shares in Edwards Lifesciences Co. (NYSE:EW) Purchased by Avanza Fonder AB - MarketBeat

Jan 18, 2025
pulisher
Jan 17, 2025

Edwards Lifesciences Co. (NYSE:EW) VP Sells $34,380.00 in Stock - MarketBeat

Jan 17, 2025
pulisher
Jan 17, 2025

Edwards Lifesciences CVP Daniel Lippis sells $34,382 in stock By Investing.com - Investing.com Canada

Jan 17, 2025
pulisher
Jan 17, 2025

Wolfe Research Downgrades Edwards Lifesciences (EW) - MSN

Jan 17, 2025
pulisher
Jan 16, 2025

Edwards Lifesciences exec sells $343,735 in stock - Investing.com

Jan 16, 2025
pulisher
Jan 16, 2025

Do You Believe in the Growth Prospects of Edwards Lifesciences Corporation (EW)? - MSN

Jan 16, 2025
pulisher
Jan 16, 2025

West Coast Financial LLC Sells 9,846 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Jan 16, 2025
pulisher
Jan 16, 2025

Wolfe Research cuts Edwards Lifesciences stock rating to Underperform - MSN

Jan 16, 2025
pulisher
Jan 16, 2025

Wolfe Research Downgrades Edwards Lifesciences (NYSE:EW) to Underperform - MarketBeat

Jan 16, 2025
pulisher
Jan 16, 2025

Should Edwards Lifesciences Stock Stay in Your Portfolio Now? - Yahoo Finance

Jan 16, 2025
pulisher
Jan 16, 2025

Meril successful at EPO against Edwards Lifesciences in heart-valve battle - JUVE Patent

Jan 16, 2025
pulisher
Jan 15, 2025

Edwards Lifesciences Corp. stock outperforms competitors despite losses on the day - MarketWatch

Jan 15, 2025
pulisher
Jan 15, 2025

Assenagon Asset Management S.A. Buys 3,506,886 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Jan 15, 2025
pulisher
Jan 13, 2025

WELLCOME TRUST LTD THE as trustee of the WELLCOME TRUST Purchases 300,000 Shares of Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Jan 13, 2025
pulisher
Jan 11, 2025

Edwards Lifesciences price target raised to $74 from $72 at Bernstein - MSN

Jan 11, 2025
pulisher
Jan 09, 2025

Edwards Lifesciences’ Q4 2024 Earnings: What to Expect - Nasdaq

Jan 09, 2025
pulisher
Jan 09, 2025

Edwards Lifesciences’ Q4 2024 Earnings: What To Expect - Barchart

Jan 09, 2025
pulisher
Jan 09, 2025

Edwards Lifesciences Co. (NYSE:EW) Receives $79.40 Consensus Target Price from Analysts - MarketBeat

Jan 09, 2025
pulisher
Jan 08, 2025

Edwards Lifesciences Corp. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch

Jan 08, 2025
pulisher
Jan 08, 2025

Edwards Lifesciences Stock Price | EW Stock Quote, News, and History - Markets Insider

Jan 08, 2025
pulisher
Jan 08, 2025

Brain Ischemia Market grow at CAGR of 7.6% Growth, Reaching $1,622 million by 2032 Globally - GlobeNewswire Inc.

Jan 08, 2025
pulisher
Jan 07, 2025

Edwards Lifesciences Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch

Jan 07, 2025
pulisher
Jan 07, 2025

Edwards Lifesciences to Present at the 43rd Annual J.P. Morgan Healthcare Conference - BioSpace

Jan 07, 2025
pulisher
Jan 06, 2025

Nordea Investment Management AB Grows Stock Holdings in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Jan 06, 2025
pulisher
Jan 06, 2025

Edwards Lifesciences Corporation (NYSE:EW) is largely controlled by institutional shareholders who own 85% of the company - Yahoo Finance

Jan 06, 2025
pulisher
Jan 03, 2025

Edwards Lifesciences price target raised to $75 from $69 at Evercore ISI - Yahoo Finance

Jan 03, 2025
pulisher
Dec 31, 2024

Edwards Lifesciences Corp. stock underperforms Tuesday when compared to competitors - MarketWatch

Dec 31, 2024
pulisher
Dec 31, 2024

Edwards Lifesciences (NYSE:EW) Share Price Crosses Above 200-Day Moving AverageHere's What Happened - MarketBeat

Dec 31, 2024
pulisher
Dec 30, 2024

Edwards Lifesciences gets FDA warning letter - Reuters

Dec 30, 2024
pulisher
Dec 28, 2024

Edwards Lifesciences Corporation (EW): Among the Cheap Healthcare Stocks to Buy Heading Into 2025 - Insider Monkey

Dec 28, 2024
pulisher
Dec 24, 2024

Edwards Lifesciences Corp. stock rises Tuesday, still underperforms market - MarketWatch

Dec 24, 2024
pulisher
Dec 24, 2024

Wolfe Research Upgrades Edwards Lifesciences (EW) - MSN

Dec 24, 2024
pulisher
Dec 23, 2024

Edwards Lifesciences Corp. stock remains steady Monday, underperforms market - MarketWatch

Dec 23, 2024
pulisher
Dec 23, 2024

Principal Financial Group Inc. Has $53.95 Million Stock Position in Edwards Lifesciences Co. (NYSE:EW) - MarketBeat

Dec 23, 2024
pulisher
Dec 23, 2024

Edwards Lifesciences Corporation's (NYSE:EW) Price Is Out Of Tune With Earnings - Simply Wall St

Dec 23, 2024
pulisher
Dec 20, 2024

Jim Cramer: Is Edwards Lifesciences (EW) Poised for a Comeback? - Insider Monkey

Dec 20, 2024
pulisher
Dec 19, 2024

Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch

Dec 19, 2024
pulisher
Dec 18, 2024

Edwards Lifesciences Corp. stock underperforms Wednesday when compared to competitors - MarketWatch

Dec 18, 2024
pulisher
Dec 17, 2024

EDWARDS ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire

Dec 17, 2024
pulisher
Dec 17, 2024

Edwards lifesciences CVP Daniel Lippis sells $185k in stock By Investing.com - Investing.com Australia

Dec 17, 2024
pulisher
Dec 17, 2024

Edwards Lifesciences' SWOT analysis: stock outlook amid TAVR challenges and TMTT growth - Investing.com

Dec 17, 2024
pulisher
Dec 17, 2024

Edwards lifesciences CVP Daniel Lippis sells $185k in stock - Investing.com India

Dec 17, 2024
pulisher
Dec 16, 2024

Daniel J. Lippis Sells 2,500 Shares of Edwards Lifesciences Co. (NYSE:EW) Stock - MarketBeat

Dec 16, 2024
pulisher
Dec 16, 2024

Assessing Edwards Lifesciences: Insights From 20 Financial Analysts - Benzinga

Dec 16, 2024
pulisher
Dec 16, 2024

Edwards Lifesciences shares upgraded to buy, target lifted on trajectory - Investing.com

Dec 16, 2024
pulisher
Dec 16, 2024

Bank of America Upgrades Edwards Lifesciences (NYSE:EW) to "Buy" - MarketBeat

Dec 16, 2024

Edwards Lifesciences Corp Stock (EW) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$84.74
price down icon 0.31%
$84.38
price down icon 0.54%
medical_devices PHG
$25.80
price up icon 0.27%
medical_devices ZBH
$109.56
price up icon 0.57%
medical_devices STE
$209.62
price down icon 0.25%
Cap:     |  Volume (24h):